Home » Uncategorized

Category Archives: Uncategorized

97th Annual Arizona Tax Conference October 8-10, 2014 in Tucson

October 8-10, 2014
JW Marriott Starr Pass Resort
Tucson AZ

http://events.r20.constantcontact.com/register/event?oeidk=a07e9mp5jpea43919ec&llr=fljn4vdab

Co-sponsored by the Arizona Department of Revenue and the Arizona Association of Assessing Officers

http://www.azdor.gov/

Join tax and public policy professionals from across Arizona at the 97th Annual Arizona Tax Conference.

This year’s conference features timely presentations on topics of interest to Arizona’s tax professionals and many concurrent sessions that enable the attendee to customize their conference experience.  

 Check out the schedule of events here.  

Register Now!

Cancellation Policy

Occasionally, unforseeable work demands prevent registrants from attending this event, even though they have registered. In such instances, it is essential that the registrant CANCEL their registration in writing. Cancellations must be directed to: Vicki Chappel at vchappel@azdor.gov. Registering for but not attending the conference is not a form of cancellation.

  • Cancellations received on or before September 8, 2014 will receive a full refund.
  • Cancellations received September 9-19, 2014 are subject to a $100 cancellation fee. In instances where payment is outstanding, you will receive an invoice for the cancellation fee.
  • No refunds will be given for cancellations received on or after September 20, 2014. 

Lodging Accommodations

J.W. Marriott Starr Pass Resort

To book your room you may call: 1.877.622.3140 or 1.506.474.2009

or book your hotel room online at the conference rate please click here. 

To receive the conference room rate, please specify that you are attending the “Arizona State Tax Conference“. 

You may guarantee your room with a major credit card. 

Hotel Rate: $86 + tax

All reservations must be made by September 26, 2014 to secure the conference rate.

Hotel Cancellations must be made a minimum of 72 hours in advance. 

***Note from Anna:

Arizona MMJ dispensaries and retail/MMJ farmers please stay on top of your tax laws. Don’t get blindsided by the IRS.

Overdose Of Prescription Drug Oxycodone Even Deadlier Than Heroin

By Pooja Bhagat | International Business Times  August 31, 2014 8:57 PM EST

http://au.ibtimes.com/articles/564650/20140831/oxycodone-opioid-drug-overdose-awareness-day.htm#.VATUp6NhBki

Shocking revelations about oxycodone, which is a commonly used opioid painkiller, have emerged during the Overdose Awareness Day held on Sunday. As per the report released by National Coronial Information Systems, oxycodone has even surpassed notorious drug heroine with respect to being the deadliest opioid drug in Australia.

During the span of five years from 2007 to 2011, more than 3000 deaths have been recorded due to overdose on this opioid-based prescription medicine. This number has surpassed the deaths caused in the same span of time by heroin overdose. As per the report, about three quarters of all opioid drug deaths are results of an overdose, particularly when these drugs were taken with other deadly narcotics and/or alcohol.

The acting CEO of Penington Institute, Wendy Dodd, shared some serious concerns with Herald Sun.com over these revelations. Penington Institute is a non-profit organization, which works closely with the issue of problematic drugs. “Heroin deaths appear to be declining which is great news, but pharmaceutical overdoses are rising alongside spiralling prescription rates,” she said.

Oxycodone is commonly used as a pain killer. It is a kind of narcotic pain medication. Another potentially dangerous medical drug identified is Fentanyl. It is available under the brand names Actiq, Duragesic, Lazanda and Sublimaze. This drug is mainly given to patients experiencing moderate to severe pain and who are already on opioid medications.

International Overdose Awareness Day is a global affair, which happens every year on August 31. It aims to raise the awareness of drug overdose and its fatal effects.

Some of the points discussed in relation to oxycodone and other opioid drugs are mentioned in the following:

  • As per the data provided to Penington institute by Australian Bureau of Statistics, deaths are occurring every day due to drug overdose in Australia.
  • Overdoses even out-numbered the road fatalities in 2012. As per the statistics, overdose deaths totalled 1,427 in 2012, while road deaths, which have been steadily declining, ended the year at 1,338.
  • Oceania, which includes Australia and New Zealand, has a higher than the world average drug mortality rate. The UNODC said there were between 1,600 and 1,900 drug-related deaths in 2012.

To contact the editor, e-mail: editor@ibtimes.com

***Note from Anna: In America marijuana is considered far more dangerous than Oxycodone.

http://www.justice.gov/dea/druginfo/ds.shtml

Schedule I

Schedule I drugs, substances, or chemicals are defined as drugs with no currently accepted medical use and a high potential for abuse. Schedule I drugs are the most dangerous drugs of all the drug schedules with potentially severe psychological or physical dependence. Some examples of Schedule I drugs are:

heroin, lysergic acid diethylamide (LSD), marijuana (cannabis), 3,4-methylenedioxymethamphetamine (ecstasy), methaqualone, and peyote

Schedule II

Schedule II drugs, substances, or chemicals are defined as drugs with a high potential for abuse, less abuse potential than Schedule I drugs, with use potentially leading to severe psychological or physical dependence. These drugs are also considered dangerous. Some examples of Schedule II drugs are:

cocaine, methamphetamine, methadone, hydromorphone (Dilaudid), meperidine (Demerol), oxycodone (OxyContin), fentanyl, Dexedrine, Adderall, and Ritalin

Schedule III

Schedule III drugs, substances, or chemicals are defined as drugs with a moderate to low potential for physical and psychological dependence. Schedule III drugs abuse potential is less than Schedule I and Schedule II drugs but more than Schedule IV. Some examples of Schedule III drugs are:

Combination products with less than 15 milligrams of hydrocodone per dosage unit (Vicodin), Products containing less than 90 milligrams of codeine per dosage unit (Tylenol with codeine), ketamine, anabolic steroids, testosterone

Schedule IV

Schedule IV drugs, substances, or chemicals are defined as drugs with a low potential for abuse and low risk of dependence. Some examples of Schedule IV drugs are:

Xanax, Soma, Darvon, Darvocet, Valium, Ativan, Talwin, Ambien

Schedule V

Schedule V drugs, substances, or chemicals are defined as drugs with lower potential for abuse than Schedule IV and consist of preparations containing limited quantities of certain narcotics. Schedule V drugs are generally used for antidiarrheal, antitussive, and analgesic purposes. Some examples of Schedule V drugs are:

cough preparations with less than 200 milligrams of codeine or per 100 milliliters (Robitussin AC), Lomotil, Motofen, Lyrica, Parepectolin

 

From  Drugrehab101.com:

http://www.drugrehab101.com/articles89.html

“…The 2004 National Survey on Drug Use and Health (NSDUH) revealed that 3,000,000 people over the age of 11 had tried OxyContin® for a nonmedical purpose, and 615,000 people tried OxyContin® for nonmedical use for the first time in 2004. But oxycodone is well in the public eye because it has widespread legal use, with 38,100,000 prescriptions in 2005, of which over 19% were for OxyContin®.

The 2006 Monitoring the Future Study revealed these figures for 2005 nonmedical use of OxyContin® by teens:

Nonmedical Use of OxyContin® by Students for the Year 2005

Grade

Percentage of Students

8th grade

1.8%

10th grade

3.2%

12th grade

5.5%

The use of oxycodones depends to a certain extent on the particular drug in question. Oxycodone is available in the U.S. as an oral solution, as tablets, and as extended release tablets. Combined with acetaminophen, it is available as an oral solution, as capsules, and as tablets. Combined with aspirin, it is available as a tablet.

OxyContin®, available as a time-release tablet, may be used intact, or crushed and chewed, snorted, or dissolved in water and then injected. The products that combine oxycodone with acetaminophen or aspirin are also abused orally.

Opioids, including Oxycodone, carry the risk of addiction, which is why they are “scheduled” drugs. They are abused both in overdoses when prescribed and used outside of prescriptions to get high, often accompanied with alcohol.

As early as the 1920s, oxycodone sold as Eukodal, was reported to create a “striking euphoria,” and its euphoric effects have been sought since.”

Other desired effects include:

  • euphoria
  • pain-killing properties
  • reduced anxiety
  • relaxation

Unsought effects include:

  • addiction
  • overdose

How is Oxycodone Used, Stats and Effects Sources:

  • emedicine.com
  • whitehousedrugpolicy.gov
  • drugabusestatistics.samhsa.gov
  • nlm.nih.gov
  • deadiversion.usdoj.gov
  • prescription-drug-rehab.com

 

Washington State:Maple Valley Physician’s License Revoked for Prescribing Controlled Drugs

For immediate release: August 27, 2014 (14-122)

Contacts:     Marqise Allen, Communications Office 360-236-4072
  Kelly Stowe, Communications Office       360-236-4022

Maple Valley physician’s license revoked for prescribing controlled drugs

OLYMPIA — State health officials have permanently revoked the license of a Maple Valley osteopathic physician for not completing required training and continuing to prescribe controlled drugs after being told not to do so.

The Board of Osteopathic Medicine and Surgery and the Washington State Department of Health initially suspended the license of Dale E. Alsager (DO.OP.00001485) in August of 2008. He was prohibited from prescribing schedule II and III controlled substances. Alsager didn’t complete mandatory training and continued to prescribe schedule III controlled substances while prohibited from the previous order. He also did not cooperate in the investigation of a more recent complaint.
The documents in this case can be seen online by clicking “Look up a health care provider” on the Department of Health website. Copies of the documents can be requested by calling 360-236-4700. The number can also be used to file complaints against health care providers in Washington.
The Board of Osteopathic Medicine and Surgery regulates osteopathic physicians in Washington. Along with the Department of Health, it monitors and enforces qualifications for licensing consistent standards of practice.
The Department of Health website is your source for a healthy dose of information. Also, find us on Facebook and follow us on Twitter.
###

8/14 Colorado Marijuana Workshop for State and Local Public Health- Recording and Materials

https://www.colorado.gov/pacific/cdphe/marijuana-workshop-state-and-local-public-health

Elyse Contreras Retail Marijuana Program & Medical Marijuana Research Grant Program

Programs Coordinator
P 303.692.6455 | F 303.782.0904
4300 Cherry Creek Drive South, Denver, CO 80246
elyse.contreras@state.co.us
We hosted the Marijuana Workshop for State and Local Public Health on Aug. 14, 2014. 
 

Agenda

Presentations:

 

Medical Marijuana Registry – Natalie Riggins

https://www.colorado.gov/pacific/sites/default/files/CHEIS-Natalie%20Riggins%20presentation.pdf

Medical Marijuana Research Grants Program – Ken Gershman

https://www.colorado.gov/pacific/sites/default/files/CHEIS-Ken%20Gershman%20presentation.pdf

Retail Marijuana: Health Effects Surveillance – Tista Ghosh

https://www.colorado.gov/pacific/sites/default/files/CHEIS-Tista%20Ghosh%20presentation.pdf

Retail Marijuana Public Helath Advisory Committee & Occupational Health and Safety Work Group – Mike Van Dyke

https://www.colorado.gov/pacific/sites/default/files/CHEIS-Mike%20VanDyke%20presentationV2.pdf

WIC Surveillance – Jill Bonczynski, Tri-County Health Department

https://www.colorado.gov/pacific/sites/default/files/CHEIS-Jill%20Bonczynski%20Presentation.pdf

Laboratory Contaminant Testing – Laura Gillim-Ross

https://www.colorado.gov/pacific/sites/default/files/CHEIS-Laura%20Gillim-Ross%20presentation.pdf

Perspective of a marijuana insider handouts – Max Montrose

https://www.colorado.gov/pacific/sites/default/files/CHEIS-Max%20Montrose%20Handout.pdf

Perspective of a marijuana insider PowerPoint presentation – Max Montrose

https://www.colorado.gov/pacific/sites/default/files/CHEIS-Max%20Montrose%20presentation.pdf

Perspectives of a recommending physician – Joe Cohen

Office of Behavioral Health Community Prevention Programs and Statewide Efforts – Stan Paprocki, Colorado Department of Human Services

 

Public Health Prevention Services – Ali Maffey, CDPHE and Heath Harmon, Boulder County Public Health

https://www.colorado.gov/pacific/sites/default/files/CHEIS-ALI-MAFFEY-PRESENTATION.pdf

 

***Note from Anna. Please take the time to read this information.

Reschedule DEA Medical Marijuana as Class Five

http://www.justice.gov/dea/druginfo/ds.shtml

 

“The Drug Enforcement Administration was created by President Richard Nixon through an Executive Order in July 1973 in order to establish a single unified command to combat “an all-out global war on the drug menace.” At its outset, DEA had 1,470 Special Agents and a budget of less than $75 million. Today, the DEA has nearly 5,000 Special Agents and a budget of $2.02 billion.”

http://www.justice.gov/dea/about/history.shtml

DEA Drug Schedules

Drugs, substances, and certain chemicals used to make drugs are classified into five (5) distinct categories or schedules depending upon the drug’s acceptable medical use and the drug’s abuse or dependency potential.

The abuse rate is a determinate factor in the scheduling of the drug; for example, Schedule I drugs are considered the most dangerous class of drugs with a high potential for abuse and potentially severe psychological and/or physical dependence.

As the drug schedule changes– Schedule II, Schedule III, etc., so does the abuse potential– Schedule V drugs represents the least potential for abuse. A Listing of drugs and their schedule are located at Controlled Substance Act (CSA) Scheduling or CSA Scheduling by Alphabetical Order.

These lists describes the basic or parent chemical and do not necessarily describe the salts, isomers and salts of isomers, esters, ethers and derivatives which may also be classified as controlled substances. These lists are intended as general references and are not comprehensive listings of all controlled substances.

Please note that a substance need not be listed as a controlled substance to be treated as a Schedule I substance for criminal prosecution. A controlled substance analogue is a substance which is intended for human consumption and is structurally or pharmacologically substantially similar to or is represented as being similar to a Schedule I or Schedule II substance and is not an approved medication in the United States. (See 21 U.S.C. §802(32)(A) for the definition of a controlled substance analogue and 21 U.S.C. §813 for the schedule.)

Schedule I

Schedule I drugs, substances, or chemicals are defined as drugs with no currently accepted medical use and a high potential for abuse. Schedule I drugs are the most dangerous drugs of all the drug schedules with potentially severe psychological or physical dependence. Some examples of Schedule I drugs are:

heroin, lysergic acid diethylamide (LSD), marijuana (cannabis), 3,4-methylenedioxymethamphetamine (ecstasy), methaqualone, and peyote

Schedule II

Schedule II drugs, substances, or chemicals are defined as drugs with a high potential for abuse, less abuse potential than Schedule I drugs, with use potentially leading to severe psychological or physical dependence. These drugs are also considered dangerous. Some examples of Schedule II drugs are:

cocaine, methamphetamine, methadone, hydromorphone (Dilaudid), meperidine (Demerol), oxycodone (OxyContin), fentanyl, Dexedrine, Adderall, and Ritalin

Schedule III

Schedule III drugs, substances, or chemicals are defined as drugs with a moderate to low potential for physical and psychological dependence. Schedule III drugs abuse potential is less than Schedule I and Schedule II drugs but more than Schedule IV. Some examples of Schedule III drugs are:

Combination products with less than 15 milligrams of hydrocodone per dosage unit (Vicodin), Products containing less than 90 milligrams of codeine per dosage unit (Tylenol with codeine), ketamine, anabolic steroids, testosterone

Schedule IV

Schedule IV drugs, substances, or chemicals are defined as drugs with a low potential for abuse and low risk of dependence. Some examples of Schedule IV drugs are:

Xanax, Soma, Darvon, Darvocet, Valium, Ativan, Talwin, Ambien

Schedule V

Schedule V drugs, substances, or chemicals are defined as drugs with lower potential for abuse than Schedule IV and consist of preparations containing limited quantities of certain narcotics. Schedule V drugs are generally used for antidiarrheal, antitussive, and analgesic purposes. Some examples of Schedule V drugs are:

cough preparations with less than 200 milligrams of codeine or per 100 milliliters (Robitussin AC), Lomotil, Motofen, Lyrica, Parepectolin

 

***Note from Anna: Reclassify medical marijuana on the DEA class schedule, allow it’s use for home grows, and tax it in reasonable fashion for retail. End the black market. Impeach, recall,or fire any cop or politician on the city, state, and federal levels who doesn’t agree.

Colorado Marijuana Tax Fifth Amendment Hearing on Friday August 22 2014

For immediate release: August 21, 2014

*Please COPY and REDISTRIBUTE*

{Denver} — There will be a preliminary injunction hearing in Denver
District Court on Friday in a lawsuit brought by marijuana civil rights
activists seeking to protect their Fifth Amendment right against
self-incrimination. Plaintiffs will argue in front of The Honorable Judge
John Madden IV that payment of marijuana taxes violates a citizen’s Fifth
Amendment right against self-incrimination, since marijuana remains illegal
under federal law.

*THE PUBLIC IS ENCOURAGED TO ATTEND THIS HEARING*

Date: Friday, August 22, 2014
Time: 9am to 12noon
Location: Denver District Court (Old Building)
1437 Bannock St.
Denver, Colorado
Courtroom #203: The Honorable Judge John Madden IV

Note: Please dress nicely and maintain quiet in the courtroom. Bring a
photo ID with, as you may have to show it to get through courthouse
security.

*BACKGROUND*
Attorney Robert J. Corry, Jr. filed the lawsuit on June 9, 2014 seeking to
permanently end Colorado’s marijuana taxes, on the grounds that payment of
the taxes forces citizens to incriminate themselves as criminals under
federal law.

The complaint was filed on behalf of an unnamed licensed medical and retail
marijuana center, the “No Over Taxation” issue committee (which campaigned
against Proposition AA, the marijuana tax issue approved by Colorado voters
in 2013) and several individuals, including Kathleen Chippi, Larisa
Bolivar, Miguel Lopez and William Chengelis.

Corry is seeking unspecified damages and a refund of all tax monies
collected by the state.

If successful, Corry’s lawsuit could be the basis for overturning ALL
regulations regarding marijuana licensing and registration in Colorado on
the same grounds.

As long as marijuana remains illegal under federal law,
states cannot require people to give any information about themselves in
order to distribute or purchase marijuana. ANY and ALL requirements to
identify oneself would result in a “real and appreciable” risk of
self-incrimination, and would require a citizen to implicate himself in
federal crimes.

As witnesses, the State of Colorado has called attorneys Brian Vicente and
Christian Sederberg, two self-proclaimed “marijuana lawyers” who helped
campaign for Amendment 64, to provide testimony to support the State’s
assertion that payment of these taxes is not incriminating.

Read more about the Fifth Amendment here:
http://en.wikipedia.org/wiki/Fifth_Amendment_to_the_United_States_Constitution

Corry cites a 1973 Colorado Supreme Court case (People vs. Duleff) that
overturned a man’s conviction for “selling marijuana without a license”
because compliance with the licensing requirement would have required that
person to violate his constitutional right against self-incrimination and
reveal a violation of federal law. Corry writes, “The Colorado Supreme
Court held specifically that the Fifth Amendment prohibits state licensing
requirements that force a person to reveal a violation of federal law.”

From the Duleff decision, Corry quotes the Colo. Sup. Ct.:
“The Fifth Amendment prohibits licensing requirements from being used as a
means of discovering past or present criminal activity which is subject to
prosecution by calling attention to the licensee and his
activities….There is no doubt that the information which Duleff would
have been required to disclose would have been useful to the investigation
of his activities, would have substantially increased the risk of
prosecution, and may well have been a direct admission of guilt under
federal law. The Fifth Amendment protects individuals from such compulsory,
incriminating disclosures and provides a complete defense to prosecution.”
– Colorado Supreme Court (1973)

Corry also cites a 1969 US Supreme Court case (Timothy Leary v. United
States) in which the highest court in the country overturned Leary’s
marijuana possession conviction and ruled that the federal Marihuana Tax
Act of 1937 was illegal, due to the fact that a person seeking a tax stamp
and complying with the law would be forced to incriminate himself, in
violation of the Fifth Amendment.

Corry writes, “Marijuana-specific taxes require plaintiffs and any other
person paying said taxes to incriminate themselves as committing multiple
violations of federal law, including but not limited to, participating in,
aiding and abetting, or conspiring to commit a ‘continuing criminal
enterprise’ and ‘money laundering.’ These illegally-collected taxes are
ultimately laundered by the State of Colorado through J.P. Morgan Chase
Bank, which also participates knowingly in the continuing criminal
enterprise.” Item 67, Corry complaint filed 6/9/14.

Corry concludes, “It is illegal for government to retain tax monies
illegally collected in violation of the constitution, so all amounts must
be returned, and all records related to previous tax payments, destroyed.”

Corry asks the Court to:
“Enter a temporary restraining order, preliminary injunction, and/or
permanent injunction ordering the Defendants, and all those acting in
concert with them, to cease and desist from enforcement of the marijuana
tax statutes, to cease and desist from any further collection, deposit, or
laundering of the marijuana taxes, for a full refund of marijuana tax
monies paid by any person or entity, and for destruction of all tax records
and identifying information after full refunds are made.”

“The state can’t have it both ways. If it’s illegal under federal law, you
cannot collect taxes on it,” says Kathleen Chippi, a plaintiff and member
of the Patient and Caregiver Rights Litigation Project. “We have another
case pending in the Colorado Supreme Court now, Coats v. Dish Network,
where Colorado Attorney General John Suthers argues that medical marijuana
patients can be fired from their jobs for using medical marijuana off-duty,
even though it is legal under state law. Suthers argues in the Coats case
that, since marijuana is still illegal under federal law, patients have no
rights.”

“Yet Suthers and Hickenlooper, as kingpins in their continuing criminal
enterprise, happily collect and spend the marijuana taxes, even though they
were collected in spite of multiple clear violations of federal law,”
Chippi concludes.

Read Boulder Weekly article on Federal Preemption issues and the Coats v.
Dish Lawsuit (5/22/14):
http://www.boulderweekly.com/article-12900-local-attorney-argues-fed-laws-donrst-apply-to-mmj.html

*FOR MORE INFORMATION*

Click here to read the complaint
No Over Taxation, et al, v. Hickenlooper, et al
http://www.cannabistherapyinstitute.com/legal/colorado/propaa.complaint.corry.pdf

People v. Duleff (Colorado Supreme Court case)
http://www.cannabistherapyinstitute.com/legal/colorado/people.v.duleff.html

US v. Leary (US Supreme Court case)
http://supreme.justia.com/cases/federal/us/395/6/

Read more about the Fifth Amendment here:
http://en.wikipedia.org/wiki/Fifth_Amendment_to_the_United_States_Constitution

Patient and Caregiver Rights Litigation Project
*DONATE ONLINE*
http://www.cannabislawsuits.com/

Denver 420 Rally
http://420rally.org/

Law Firm of Robert J. Corry, Jr.
http://www.robcorry.com/

*PRESS CONTACTS*

Contact: Robert J. Corry, Jr.: (303) 634-2244
Kathleen Chippi: 888-EAT-HEMP (888-328-4367)

Provided as a Public Service by the:
Cannabis Therapy Institute
Phone: 877-420-4205
Web: http://www.CannabisTherapyInstitute.com/
Email: info@cannabistherapyinstitute.com

 

***Note from Anna: Fight for your right to cannabis or lose it. The politicians have made it very,very clear that all marijuana cultivation is going into the full control of the Federal government, no matter what the state governors think. Dispensaries, activists, and patients had better pay 100 percent attention to this case.  Every state in America is looking at Colorado for direction with setting,or eliminating, cannabis legalization laws.

If the Colorado activists lose, patients in all of the marijuana states can expect mediocre mass-produced GMO’d, barely effective weed for the little people and high-quality organic cannabis for the rich.That is if it isn’t banned altogether due to quality control, supply and demand, or greed issues by the people in control of it’s cultivation.

If citizens refuse to participate in making sure cannabis is legal then definitely learn to grow your own, but don’t be surprised if home grows of any size are met with full police/FBI/DEA response. Rich people will not allow for the poor people to prosper financially with cannabis because it means THEY lose money and the citizens would be united to vote out ALL of the politicians who betrayed them.

Time is running out until the big money fake activists and lobbyists, hell-bent on locking up cannabis for the friends, politicians, and big businesses who pay them, betray the MMJ patients. The lobbyists and politicians will absolutely betray their constituents for Election 2016 profits. Voter abuses have happened before, and they will happen again if the citizens do not very closely monitor the actions of their politicians.

 

AZ Marijuana Cards Likely to Be Accepted at Nevada Dispensaries

http://azmarijuana.com/ By:   |   Posted : Aug.14.14

Nevada Marijuanahttp://azmarijuana.com/arizona-medical-marijuana-news/nevada-dispensaries-accept-arizona-marijuana-cards/

Authorities in Nevada are working on a plan that would allow medical marijuana patients from other states, including Arizona, to purchase medical marijuana at Nevada dispensaries, which will be opening in early 2015.

The bureau chief of the Nevada Division of Public and Behavioral Health said that Nevada’s new medical marijuana program will allow Arizona residents to shop at dispensaries if they are part of the medical marijuana program in Arizona.

Brian Sandoval, the governor of Nevada, has officially said that up to 66 dispensaries will open all over the state, with the first expected to open in Las Vegas at the beginning of 2015.

According to state law, Nevada dispensaries can choose to honor out of state medical marijuana cardholders as long as the state that issued their license has an electronic database of patients that “allows the Division and medical marijuana dispensaries in (Nevada) to access the database.”

This measure would obviously need to first be approved by authorities in Arizona.  Will Humble, director of the Arizona Department of Health Services, is hesitant to believe that this law would ever work out in conjunction with Arizona cardholders because the system in which medical marijuana is sold and regulated is specific to Arizona dispensaries.  However, Nevada authorities are confident that once the organized system is functioning by early 2015, their dispensaries won’t even need to access the database in Arizona, and that onsite dispensary agents will be able to validate the out-of-towners’ licenses.

There are more than a few details that need ironing out, but if all goes according to plan, Arizona medical marijuana cardholders and other states will have a few more reasons to visit Las Vegas next year.

 

Japan to Start Exporting Fukushima Rice to Singapore / “Singapore Was Convinced to Lift Import Restriction”

Rice produced in Fukushima is going to be exported to Singapore.

JA Zen-Noh (The National Federation of Agricultural Cooperative Associations) announced on 8/18/2014.

Since 311, the government of Singapore banned importing Fukushima rice. JA Zen-Noh comments they have convinced the government of Singapore to deregulate the safety level of rice.

Currently the press release is removed from the website of JA Zen-Noh for some reason.

 

http://search.zennoh.or.jp/bizsearch_asp/search?corpId=atc130002&vc=1&layout=1&hits=10&q=%E3%82%B7%E3%83%B3%E3%82%AC%E3%83%9D%E3%83%BC%E3%83%AB%E3%80%80%E8%BC%B8%E5%87%BA&p=1&t%5B%5D=1

 

http://maguro.2ch.sc/test/read.cgi/poverty/1408364601/l50

 

 

You read this now because we’ve been surviving until today.

_____

Français :

Le Japon va commencer à exporter du riz de Fukushima sur Singapour / “Singapour a été convaincu pour lever les restrictions d’importation”

 

Le riz produit à Fukushima va être exporté sur Singapour.

JA Zen-Noh (la Fédération Nationale des Associations de Coopératives Agricoles Japonaises) l’a annoncé ce 18 août 2014.
Le gouvernement de Singapour avait interdit l’importation du riz de Fukushima depuis le 11-3. JA Zen-Noh déclare qu’ils ont convaincu le gouvernement de Singapour de déréguler le niveau de sécurité du riz.

Actuellement, le communiqué de presse a été retiré du site web de la JA Zen-Noh.

http://search.zennoh.or.jp/bizsearch_asp/search?corpId=atc130002&vc=1&layout=1&hits=10&q=%E3%82%B7%E3%83%B3%E3%82%AC%E3%83%9D%E3%83%BC%E3%83%AB%E3%80%80%E8%BC%B8%E5%87%BA&p=1&t%5B%5D=1

http://maguro.2ch.sc/test/read.cgi/poverty/1408364601/l50

Vous pouvez lire ceci parce que nous avons survécu jusqu’à aujourd’hui.

 

***Note from Anna: If that radioactive rice spreads and mixes with Monsanto crops farms worldwide will be contaminated.

Fake Charities, Drug Cartels, Ransom and Extortion: Where Islamist Group Boko Haram Gets Its Cash

Fake Charities, Drug Cartels, Ransom and Extortion: Where Islamist Group Boko Haram Gets Its Cash

http://www.ibtimes.com/fake-charities-drug-cartels-ransom-extortion-where-islamist-group-boko-haram-gets-its-cash-1585743

  • Boko Haram Bomb_Nigeria
    A security barrier marks the scene of a car bomb explosion at St. Theresa Catholic Church (background) at Madalla, Suleja, just outside Nigeria’s capital Abuja on Dec. 25, 2011. Islamist militant group Boko Haram said it planted bombs that exploded on Christmas Day at churches in Nigeria, one of which killed at least 27 people on the outskirts of the capital. Reuters/Afolabi Sotunde
  • Boko Haram attacks
    A woman walks past homes destroyed by the Islamist group Boko Haram in Bama, Borno State on Feb. 20, 2014. Reuters
  • Boko Haram Bomb_Nigeria
    A security barrier marks the scene of a car bomb explosion at St. Theresa Catholic Church (background) at Madalla, Suleja, just outside Nigeria’s capital Abuja on Dec. 25, 2011. Islamist militant group Boko Haram said it planted bombs that exploded on Christmas Day at churches in Nigeria, one of which killed at least 27 people on the outskirts of the capital. Reuters/Afolabi Sotunde
  • Boko Haram attacks
    A woman walks past homes destroyed by the Islamist group Boko Haram in Bama, Borno State on Feb. 20, 2014. Reuters

Just over a year ago, armed men on motorcycles entered a national park in Cameroon, near the Nigerian border, and swiftly abducted a family of vacationing French tourists — a husband and wife and their four children, along with their uncle.

Two months later, the kidnappers released the hostages along with 16 others in exchange for a cool $3.15 million. The transaction was made by French and Cameroonian negotiators, but it was not divulged who made the payments, according to Reuters.

So landed another cash infusion into the coffers of Boko Haram, the West African jihadist militia that has now gained worldwide infamy through the mass kidnapping of school girls in northern Nigeria. Long before its latest wave of attacks, the Islamist group has efficiently financed violent acts in the service of its mission to impose Shariah law through a combination of lucrative criminal enterprises, say experts who track the group. In addition to kidnappings, Boko Haram has secured financing through extortion, cooperation with international drug cartels and operating fake charities, these experts say.

“What is certain about Boko Haram is that the organization is very well funded; without an ever-increasing cash flow, the movement would have died out long ago,” reads a report from the Terrorism Research and Analysis Consortium, a research initiative of the reference publisher Beacham Group.

About a decade ago, shortly after Boko Haram was founded, it drew the majority of its funds from people in surrounding communities who supported its goal of imposing Islamic law while ridding Nigeria of Western influences, according to a report from the National Consortium for the Study of Terrorism and Responses to Terrorism (START) based at the University of Maryland. But that means of fundraising was inherently limited in a country in which 54 percent of people are classified as “extremely poor” by the World Bank.

In more recent times, Boko Haram has broadened its funding by drawing on foreign donors, and other ventures such as fake charity organizations, extortion, and deals with global drug cartels, according to the START report. Its most recent foray — the kidnapping of 276 schoolgirls to sell on the black market as “wives” — is merely the outgrowth of a coherent strategy to find funds for expansion through whatever means necessary.

The term Boko Haram translates to “Western education is forbidden,” in the local Hausa language of the predominantly Muslim region in northern Nigeria where the group is based.

Since its formation in the early 2000s, the militia has been carrying out violent attacks around the country. Since 2009, when the group’s founding leader was killed and replaced by his second-in-command, the attacks have grown significantly more violent and intense, according to the START report. Last year, the U.S. State Department officially designated the group as a “foreign terrorist organization.”

“What Boko Haram achieved in less than a year is quite remarkable,” wrote David Doukhan of the International Institute for Counter-Terrorism, in a 2013 report, citing their reign over many parts of northeastern Nigeria, the institution of Sharia law, tax collection and an Islamic education system to recruit youth to their cause.

This expansion has required increasingly large sources of funding, which has apparently led Boko Haram to ratchet up its methods of raising money.

Boko Haram Targets Despite religious and political overtones, the majority of Boko Haram’s targets have been private citizens.  National Consortium for the Study of Terrorism and Responses to Terrorism (START) / IBTimes

 

“Perhaps less sophisticated than other tactics, kidnapping has become one of the group’s primary funding sources,” wrote Jacob Zenn, African and Eurasian affairs analyst at The Jamestown Foundation, in a recent report.

But the group receives steady support from abroad, including from Al-Qaeda in the Islamic Maghreb, according to the U.S. State Department, while using links to that terrorist group to secure further donations from sympathizers in the United Kingdom and Saudi Arabia, along with weapons and training.

An unnamed United States intelligence official last week told The Daily Beast that the Islamist group had received “strategic direction” from Osama bin Laden.

Boko Haram cloaks its sources of finance through the crafty use of a highly decentralized distribution network, say experts. The group employs an Islamic model of money transfer called “hawala,” based on an honor system and a global network of agents that leaves no trace.

“The very features which make hawala attractive to legitimate customers — efficiency, anonymity and lack of a paper trail — also make the system attractive for the transfer of illicit funds,” reads a report from the U.S. Treasury Department.

Other direct fundraising includes fake charities and nonprofits. Some have reported that the group receives regular payment from local leaders in northern Nigeria to protect their land.

An untraceable flow of money plus loosely guarded borders has created an ideal environment for black market trade. The porosity of Nigeria’s borders offers the group a steady flow of weapons, training, radicalization and funding.

A 2012 report from the Inter-University Center for Terrorism Studies alleges that Nigerian terrorist groups are financed by drug cartels in Latin America.

Lauretta Napoleoni, an Italian journalist and expert on terrorist finance, said this began to happen when the 2001 Patriot Act made it difficult to transfer drugs through the U.S. to Europe.

“Nobody wants to admit that cocaine reaches Europe via West Africa,” said Napoleoni. “This kind of business is a type of business where Islamic terrorist organizations are very much involved.”

Beyond drugs, Boko Haram has joined other criminal groups in Africa in the billion-dollar rhino and elephant poaching industry, according to a recent report from Born Free USA, a wildlife conservation organization.

“While impoverished locals are enlisted to pull the triggers, it is highly organized transnational crime syndicates and militias that run the poaching and reap the lion’s share of the profits, funding terrorism and increasingly war,” wrote New Scientist’s Richard Shiffman.

Using these extensive networks, Boko Haram members can smuggle anything from sugar and flour to weapons or even people across international borders. This, plus kidnapping ransoms and donations from abroad, is one of the most important factors keeping them in business.

Earlier this week, the U.S. State Department announced plans to further its efforts to counter Boko Haram, given the importance of Nigeria as an economic and political leader in Africa.

“The U.S. has a vital interest in helping to strengthen Nigeria’s democratic institutions, boost Nigeria’s prosperity and security, and ensure opportunity for all of its citizens,” according to a public statement.

A major part of their plan includes a counterterrorism finance program, that “aims to restrict Boko Haram’s ability to raise, move and store money.”

CDPHE Meeting on Retail Marijuana Surveillance – Thursday 8/14/2014-Patients and Press *Not* Invited

For immediate release: Aug. 13, 2014

Cannabis Press Association
http://www.cannabispressassociation.com/

Patient and Caregiver Rights Litigation Project
http://www.cannabislawsuits.com/
888-EAT-HEMP

{Denver} — The Colorado Department of Public Health and Environment
(CDPHE) will be holding an all-day meeting on Thursday, Aug. 14, concerning
their expanding roles in “retail marijuana surveillance” and other areas.

*PHYSICAL LOCATION OF MEETING*
Courtyard Marriott Cherry Creek
Skyline Ballroom
1475 South Colorado Blvd.
Denver, CO 80222
Workshop begins at 8:30 am

The CDPHE had previously only regulated medical marijuana. Their new roles in retail marijuana involve at least 6 different departments within the CDPHE. (See page 10 of “Marijuana and CDPHE” presentation below.)

The meeting will be held at the Courtyard Marriott in Denver, but there
will also be a live webinar available (See below for details.)

According to the CDPHE, “no media” will be allowed to attend the meeting,
and the agenda shows that “no patients” have been invited to share their
views in any manner, even though the subject matter directly concerns them.

The Cannabis Press Association (CPA), working with the Patient and
Caregivers Rights Litigation Project (PCRLP), discovered the meeting, after
several patients received an email invitation asking them to register for
the meeting, which was apparently sent accidentally by the CDPHE to the
wrong email distribution list.

In the email, Elyse Contreras, Programs Coordinator for the Retail
Marijuana Program & Medical Marijuana Research Grant Program at the CDPHE,
stated that the purpose of the Aug. 14 meeting is “to update our local
partners on latest information regarding marijuana surveillance, prevention
efforts, medical research, lab regulations, infused product safety and
more!”

Contreras’ invitation stated that “no media” would be allowed to attend.

When the CDPHE discovered they had sent the email invitation to patients in
error, they immediately removed the online registration form from their
website.

The Cannabis Press Association filed a Colorado Open Records Act (CORA)
request last week, asking for the location and webinar login information
for the meeting, as well as a request for the list of invitees to the
meeting.

The CDPHE ignored the CORA requests. However, CPA was able to obtain the
information from reliable sources. (See below.)

*SURVEILLANCE OF PREGNANT WOMEN*
Many topics will be covered at the all-day meeting. A primary focus will be
how the CDPHE will be performing “surveillance” on pregnant women to
determine whether cannabis used during pregnancy is harmful to children.

According to a “Marijuana and Pregnancy” presentation on the CDPHE website,
one of the new CDPHE programs includes “Birth Registry Surveillance”, which
is defined as “surveillance to determine if marijuana could be a factor in
the development of adverse birth outcomes” and includes a “thorough review
of maternal medical records” (See page 9 of “Marijuana and Pregnancy”
presentation below.)

Kathleen Chippi of the Patient and Caregiver Rights Litigation Project sees
this as another attack on patients. “This secret meeting is just another
attack on medical marijuana patients. They want to screen all birth mothers
for cannabis? The CDPHE doesn’t test new moms for GMOs, pesticides,
fracking fluids, caffeine, sugar, or pharmaceutical chemicals, so why focus
on THC, which has been used safely by humans for over 10,000 years?
Cannabis was actually prescribed commonly to ease pregnancy and the
birthing process before it was made illegal in 1937. Natural cannabinoids
(endocannabinoids) are actually abundant in all breast milk and research
has shown that they are essential to a newborn’s development.”

See: Cannabinoids, like those found in marijuana, occur naturally in human
breast milk
http://www.naturalnews.com/036526_cannabinoids_breast_milk_THC.html#ixzz3AKr2v8PH

===================================================================

*MEETING AGENDA*
Click here for agenda for the Aug. 14, 2014 CDPHE/DOR meeting:
http://cannabispressassociation.com/docs/CDPHE.Agenda.for.State.Local.Workshop-8.14.14.pdf

NOTE: The CDPHE claims that this is not a public meeting, but have refused
to provide a list of the official invitees. If you want to attend in
person, it is recommended to arrive early to try to cajole a seat out of
your public officials.

===================================================================
*WEBINAR LOGIN INFORMATION*
From: “Contreras – CDPHE, Elyse” <elyse.contreras@state.co.us>
Date: August 13, 2014 10:51:24 AM MDT
To: undisclosed-recipients:;
Subject: 8/14 Marijuana Webinar Details
Marijuana Workshop for State and Local Public Health

Follow the directions below to join the webinar beginning at 8:30 am
Thursday, August 14th. This is an all day work shop, the agenda is
attached.

This meeting is intended to allow local public health agency
representatives the opportunity to learn more abut marijuana regulation in Colorado.  No public comment or questions will be taken as the meeting is not considered an open meeting as defined in the Colorado Open Meetings Law, Section 24-6-401 et seq. 

Questions on the topics discussed can be
sent to medical.marijuana@state.co.us.

To join the meeting:
https://cdphe.adobeconnect.com/r6e3dlu1pg2/
—————-
If you have never attended an Adobe Connect meeting before:

Test your connection:
https://cdphe.adobeconnect.com/common/help/en/support/meeting_test.htm

Get a quick overview: http://www.adobe.com/products/adobeconnect.html

Elyse Contreras
Programs Coordinator
Retail Marijuana Program & Medical Marijuana Research Grant Program
P 303.692.6455  |  F 303.782.0904
4300 Cherry Creek Drive South, Denver, CO 80246
elyse.contreras@state.co.us
===================================================================

*RELATED CDPHE PRESENTATIONS*
“Marijuana and CDPHE” presentation
http://cannabispressassociation.com/docs/CDPHE.Marijuana.and.CDPHE.Presentation.CORA4.pdf

“Marijuana and Pregnancy” presentation
http://cannabispressassociation.com/docs/CDPHE.Marijuana.Pregnancy.Presentation.pdf

===================================================================
NOTE: This information was obtained as a public service by volunteers
working with the Cannabis Press Association (CPA), working with the Patient
and Caregivers Rights Litigation Project (PCRLP). Please be generous and
make a donation today.

===================================================================

For immediate release: Aug. 13, 2014

Cannabis Press Association
http://www.cannabispressassociation.com/

Patient and Caregiver Rights Litigation Project
http://www.cannabislawsuits.com/
888-EAT-HEMP


Provided as a Public Service by the:
Cannabis Press Association
“Fighting over 77 years of lies and mis-information
with over 10,000 years of history and fact.”
Web: http://www.cannabispressassociation.com/
Email: info@cannabispressassociation.com

***Note from Anna: I wish the DEA officers went after legal (and illegal) methamphetamine,steroid, and Prozac abusers with the same intensity used for illegally profiling legal medical marijuana patients.

Colorado has sold out to big pharmaceutical companies and their petty political lobbyists. It’s disturbing to watch how easy it is for judges and cops to abuse the weakest among them while running like their asses are on fire away from violent offenders on legally-distributed methamphetamines.

Stats on Meth in Colorado:

http://www.justice.gov/archive/ndic/pubs4/4300/meth.htm

National Drug Intelligence Center
Colorado Drug Threat Assessment
May 2003

“…Methamphetamine abuse is increasingly prevalent in Colorado. The number of methamphetamine-related treatment admissions to publicly funded facilities in the state increased from 1,748 in 1997 to 2,037 in 2001, according to data from ADAD. (See Table 1 in Overview section.) Since 1999 treatment admissions for methamphetamine abuse have increased each year, while admissions for cocaine, heroin, and marijuana have declined. According to ADAD, more than 83 percent of patients treated for methamphetamine abuse in 2001 were Caucasian, 54 percent were male, and nearly 33 percent were 35 or older. Nearly 43 percent of methamphetamine abusers treated during 2001 smoked the drug, 32 percent injected it, 19 percent snorted it, and 6 percent used some other method or multiple methods of administration.”

http://www.narconon.org/drug-information/colorado-drug-addiction.html

From Narconon International:

“…Colorado is crossed by eight Interstates: I-15, I-25, I-70, I-76, I-80, I-84, I-90 and I-94. The central location and high ethnic population of Denver and its suburbs makes it a perfect distribution center for drugs coming into the U.S. across the Canadian border, or for drugs being trafficked north from the Southwest border. Fifteen Ports of Entry (POE) from Canada exist in Montana, and Interstates 15 and 90 link these POEs with Denver and Salt Lake City, both major drug distribution points.

…The most dangerous aspect of the drug scene in Colorado and its cities is that drug trafficking and use is on the increase. The biggest threat is the highly addictive and physically damaging ice methamphetamine. Recent supplies of meth have been more pure and lower cost than earlier supplies.”

From Johnny Green at the Weed Blog April 3, 2013:

http://www.theweedblog.com/marijuana-patents-us-patents-on-medical-procedures-involving-cannabinoids/

Spain Study Confirms Hemp Oil Cures Cancer
http://www.endalldisease.com/spain-st…

Federal Government Reports that Marijuana Kills Cancer Cells
http://www.nbcnews.com/id/51148243/ns…

US Patent 4837228
Cannabichromene (CBC)
http://www.google.com/patents/US4837228

US Patent 4189491
Glaucoma Treatment
http://www.google.com/patents/US4189491

US Patent 5631297
Anandamide Compounds
http://www.google.com/patents/US5631297

US Patent 6132762
Pain, inflammation and arthritis
http://www.google.com/patents/US6132762

US Patent 6410588
Cannabidiol and inflammatory diseases
http://www.google.com/patents/US6410588

US Patent 6974568
Treatment for coughs
http://www.google.com/patents/US6974568

US Patent 6630507
Inflammatory and autoimmune diseases
Strokes, Alzheimer’s and Parkinson’s
http://www.google.com/patents/US6630507

US Patent 7741365
Novel polycyclic cannabinoid analogs
http://www.google.com/patents/US7741365

US Patent 7597910
Prostate cancer and prostatitis
http://www.google.com/patents/US7597910

US Patent 7977107
Detecting traces of cannabinoids
http://www.google.com/patents/US7977107

US Patent 8071641
Diabetes and insulitis
http://www.google.com/patents/US8071641

US Patent 8242178
Cannabidiol and autoimmune hepatitis
http://www.google.com/patents/US8242178

US Patent 8034843
Nausea, vomiting and motion sickness
http://www.google.com/patents/US8034843

US Patent Application 20100292345
Cannabigerol (CBG)
http://www.google.com/patents/US20100…

US Patent Application 20080181942
Multiple sclerosis and MS relapse
http://www.google.com/patents/US20080…

US Patent Application 20090197941
Chronic Obstructive Pulmonary Disease
http://www.google.com/patents/US20090…

US Patent Application 20100204312
Treating cell proliferation and cancers
http://www.google.com/patents/US20100…

US Patent Application 20080262099
Inhibition of tumour cell migration
http://www.google.com/patents/US20080…

US Patent Application 20100222437
Gastrointestinal inflammatory and cancers
http://www.google.com/patents/US20100…

Cannabis and Cannabinoid Research Studies…

Scientific Proof Cannabinoids Kill Cancer Cells :

http://youtu.be/mFBBTnv5Xbs

http://redd.it/18qiwn
http://phoenixtears.ca
http://www.phoenixtearsfoundation.com…

Copy and paste links into address bar (one at a time) :

ncbi.nlm.nih.gov/pubmed/19638490
ncbi.nlm.nih.gov/pubmed/22776349
ncbi.nlm.nih.gov/pubmed/16682966
ncbi.nlm.nih.gov/pubmed/12648025
ncbi.nlm.nih.gov/pubmed/19914218
ncbi.nlm.nih.gov/pubmed/15026328
ncbi.nlm.nih.gov/pubmed/16893424
ncbi.nlm.nih.gov/pubmed/15361550
ncbi.nlm.nih.gov/pubmed/19889794
ncbi.nlm.nih.gov/pubmed/19015962
ncbi.nlm.nih.gov/pubmed/19608284
ncbi.nlm.nih.gov/pubmed/17237277
ncbi.nlm.nih.gov/pubmed/11586361
ncbi.nlm.nih.gov/pubmed/14692532
ncbi.nlm.nih.gov/pubmed/16571653
ncbi.nlm.nih.gov/pubmed/18286801
ncbi.nlm.nih.gov/pubmed/16250836
ncbi.nlm.nih.gov/pubmed/17934890
ncbi.nlm.nih.gov/pubmed/12052046
ncbi.nlm.nih.gov/pubmed/19189054
ncbi.nlm.nih.gov/pubmed/18354058
ncbi.nlm.nih.gov/pubmed/19047095
ncbi.nlm.nih.gov/pubmed/10913156
ncbi.nlm.nih.gov/pubmed/9653194
ncbi.nlm.nih.gov/pubmed/18088200
ncbi.nlm.nih.gov/pubmed/16909207
ncbi.nlm.nih.gov/pubmed/17342320
ncbi.nlm.nih.gov/pubmed/19059457
ncbi.nlm.nih.gov/pubmed/12723496
ncbi.nlm.nih.gov/pubmed/19442536
ncbi.nlm.nih.gov/pubmed/16728591
ncbi.nlm.nih.gov/pubmed/19539619
ncbi.nlm.nih.gov/pubmed/16500647
ncbi.nlm.nih.gov/pubmed/19189659
ncbi.nlm.nih.gov/pubmed/14617682
ncbi.nlm.nih.gov/pubmed/18938775
ncbi.nlm.nih.gov/pubmed/11106791
ncbi.nlm.nih.gov/pubmed/19394652
ncbi.nlm.nih.gov/pubmed/20336665
ncbi.nlm.nih.gov/pubmed/19442435
ncbi.nlm.nih.gov/pubmed/15451022
ncbi.nlm.nih.gov/pubmed/18197164
ncbi.nlm.nih.gov/pubmed/16835997
ncbi.nlm.nih.gov/pubmed/11903061
ncbi.nlm.nih.gov/pubmed/17675107
ncbi.nlm.nih.gov/pubmed/17202146
ncbi.nlm.nih.gov/pubmed/19425170
ncbi.nlm.nih.gov/pubmed/18454173
ncbi.nlm.nih.gov/pubmed/17065222
ncbi.nlm.nih.gov/pubmed/10700234
ncbi.nlm.nih.gov/pubmed/16787257
ncbi.nlm.nih.gov/pubmed/15958274
ncbi.nlm.nih.gov/pubmed/16139274
ncbi.nlm.nih.gov/pubmed/16624285
ncbi.nlm.nih.gov/pubmed/16616335
ncbi.nlm.nih.gov/pubmed/11269508
ncbi.nlm.nih.gov/pubmed/19690545
ncbi.nlm.nih.gov/pubmed/12511587
ncbi.nlm.nih.gov/pubmed/20307616
ncbi.nlm.nih.gov/pubmed/16818634
ncbi.nlm.nih.gov/pubmed/17952650
ncbi.nlm.nih.gov/pubmed/16818650
ncbi.nlm.nih.gov/pubmed/16596790
ncbi.nlm.nih.gov/pubmed/15638794
ncbi.nlm.nih.gov/pubmed/15275820
ncbi.nlm.nih.gov/pubmed/12133838
ncbi.nlm.nih.gov/pubmed/18339876
ncbi.nlm.nih.gov/pubmed/9771884
ncbi.nlm.nih.gov/pubmed/10570948
ncbi.nlm.nih.gov/pubmed/12182964
ncbi.nlm.nih.gov/pubmed/19229996